Insights & Resources – COD Research – Designing Therapies For Future

The Evolution of PRO Collection: From Paper Diaries to ePRO Systems

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Biometrics

Clinical Services

CT Quality Assurance

Medical Affairs

Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment

Strategic Planning for Patient Recruitment

EMA
FDA
MHRA

Product Management Service (PMS) public API beta release - Technical overview and live demo, Online, from 13 July 2026, 14:00 (CEST) to 13 July 2026, 15:30 (CEST)
Source: EMA Published on 2026-09-01
Managing product data quality in PMS: processes, known issues, current status and best practices, Online, from 21 July 2026, 14:00 (CEST) to 21 July 2026, 15:30 (CEST)
Source: EMA Published on 2026-09-01
Human medicines European public assessment report (EPAR): Myqorzo, aficamten, Date of authorisation: 12/02/2026, Revision: 2, Status: Authorised
Source: EMA Published on 2026-09-01
Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 9, Status: Authorised
Source: EMA Published on 2026-09-01
ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 22 October 2026
Source: EMA Published on 2026-09-01
Voluntary data submission pilot to advance innovative alternatives to animal testing
Source: EMA Published on 2026-09-01

Read More